期刊文献+

中药川贝含药血清对支气管平滑肌细胞及血管内皮细胞生长因子的影响 被引量:3

Effects of Bulbus Fritillariae Cirrhosae medicated serum on bronchial smooth muscle cells and vascular endothelial growth factor
下载PDF
导出
摘要 目的观察中药川贝含药血清对支气管平滑肌细胞(BSMC)增殖,管道形成及血管内皮细胞生长因子(VEGF)表达的影响。方法卵蛋白(OVA)复制哮喘小鼠模型,制备川贝含药血清。体外培养BSMC,随机分为空白血清组,低剂量组和高剂量组。检测BSMC增殖率,管道形成长度,VEGF及VEGF m RNA的表达。结果与空白血清组比较,低剂量组和高剂量组显著降低BSMC增殖,管道形成长度,VEGF和VEGF m RNA的表达(P<0.05)。结论中药川贝含药血清可抑制BSMC增殖,管道形成长度,其机制可能与其抑制VEGF的表达有关。 Objective To investigate the effect of Bulbus Fritillariae Cirrhosae medicated serum on the proliferation of the bronchial smooth muscle cells (BSMC), the tube formation and the expressions of vascular endothelial growth factor (VEGF) in BSMC. Methods The murine were sensititized and challenged with ovalbumin (OVA) to establish asthma model and Bulbus Fritillariae Cirrhosae medicated serum was prepared. The BSMC were cultured in vitro and randomly divided into the blank serum group, the low dose group and the high dose group. The proliferations of BSMC, the lengths of the tube formation, the expressions of VEGF and VEGF mRNA were detected. Results Compared with the blank serum group, the proliferations of BSMC, the lengths of the tube formation, the expressions of VEGF and VEGF mRNA of the low dose group and the high dose group were increased significantly (P 〈 0.05). Conclusion Bulbus FritiUariae Cirrhosae medicated serum can inhibit the proliferations of BSMC and the lengths of the tube formation, and the possible mechanisms may be related to reduce the expressions of VEGF.
出处 《中国医药导报》 CAS 2017年第26期13-16,共4页 China Medical Herald
基金 牡丹江医学院科学技术研究项目(ZS201516)
关键词 川贝 哮喘 支气管平滑肌细胞 血管内皮生长因子 Bulbus Fritillariae Cirrhosae medicated serum Asthma Bronchial smooth muscle cells Vascular en- dothelial growth factor
  • 相关文献

参考文献11

二级参考文献134

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2042
  • 2邱晨,史菲.肺表面活性物质对哮喘大鼠血清一氧化氮、丙二醛含量及超氧化物歧化酶活性的影响[J].中国呼吸与危重监护杂志,2004,3(5):311-313. 被引量:9
  • 3王志虹,林江涛,农英,周童亮.血管内皮生长因子受体抑制剂对小鼠支气管哮喘模型气道炎症和气道重塑的影响[J].中华结核和呼吸杂志,2005,28(11):755-759. 被引量:20
  • 4Lee SY, Kwon S, Kim KH, Moon HS, Song JS, Park SH, et al. Expression of vascular endothelial growth factor and hypoxia-inducible factor in the airway of asthmatic patients [ J ]. Ann Allergy Asthma Immunol, 2006, 97(6) : 794-799.
  • 5Yu P, Kodadek T. Dynamics of the hypoxia-inducible factor-1-vascular endothelial growth factor promoter complex [ J ]. J Biol Chem, 2007, 282 (48): 35035-35045.
  • 6Kim SR, Lee KS, Park SJ, Min KH, Choe YH, Moon H, et al. Involvement of sirtuin 1 in airway inflammation and hyperrespons- iveness of allergic airway disease [ J ]. J Allergy Clin Immunol, 2010, 125(2) : 449-460.
  • 7Yamaguchi M, Niimi A, Matsumoto H, Ueda T, Takemura M, Matsuoka H, et al. Sputum levels of transforming growth factor-betal in asthma: relation to clinical and computed tomography findings [ J ]. J Investig Allergol Clin Immunol, 2008,18(3) : 202-206.
  • 8Hoshino M, Aoike N, Takahashi M, Nakamura Y, Nakagawa T. Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma[J]. Eur Respir J, 2003, 21 (5) : 804-809.
  • 9Baluk P, Lee CG, Link H, Ator E, Haskell A, Elias JA, et al. Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways [ J ]. Am J Pathol, 2004,165 (4) : 1071-1085.
  • 10Yuksel H, Kose C, Yilmaz O, Ozbilgin K, Degirmenci PB, Pinar E, et al. Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component [ J ]. Clin Exp Allergy, 2007, 37(8) : 1183-1188.

共引文献65

同被引文献33

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部